Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncotarget

Showing results (11-20 of 26,728) with videos related to

Pageof 2,673
Sort By:
Oncotarget|December 24, 2010
PI3Kα inhibitors that inhibit metastasisOleg Schmidt-Kittler, Jiuxiang Zhu, Jian Yang, et al.
Oncotarget|October 9, 2010
Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistanceLei Shi, Siqing Wang, Maurizio Zangari, et al.
Oncotarget|November 30, 2010
CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cellsJuan R Cubillos-Ruiz, Diana Martinez, Uciane K Scarlett, et al.
Oncotarget|March 8, 2011
The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic targetGabriel J Villares, Maya Zigler, Menashe Bar-Eli
Oncotarget|March 8, 2011
miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinomaNijiro Nohata, Yaeko Sone, Toyoyuki Hanazawa, et al.
Oncotarget|March 8, 2011
FAM190A rearrangements provide a multitude of individualized tumor signatures and neo-antigens in cancerFrancesca Scrimieri, Eric S Calhoun, Kalpesh Patel, et al.
Oncotarget|August 12, 2010
Overexpression of POLQ confers a poor prognosis in early breast cancer patientsGeoff S Higgins, Adrian L Harris, Remko Prevo, et al.
Oncotarget|October 16, 2010
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cellsEmily J Noonan, Robert F Place, Shashwati Basak, et al.
Oncotarget|February 9, 2011
Src activates Abl to augment Robo1 expression in order to promote tumor cell migrationP Raaj Khusial, Bhaskar Vadla, Harini Krishnan, et al.
Oncotarget|April 14, 2011
Biomarkers in NHLSami N Malek
Pageof 2,673

Showing results (11-20 of 26,728) with videos related to

Sort By:
Pageof 2,673
Oncotarget|December 24, 2010
PI3Kα inhibitors that inhibit metastasisOleg Schmidt-Kittler, Jiuxiang Zhu, Jian Yang, et al.
Oncotarget|October 9, 2010
Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistanceLei Shi, Siqing Wang, Maurizio Zangari, et al.
Oncotarget|November 30, 2010
CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cellsJuan R Cubillos-Ruiz, Diana Martinez, Uciane K Scarlett, et al.
Oncotarget|March 8, 2011
The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic targetGabriel J Villares, Maya Zigler, Menashe Bar-Eli
Oncotarget|March 8, 2011
miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinomaNijiro Nohata, Yaeko Sone, Toyoyuki Hanazawa, et al.
Oncotarget|March 8, 2011
FAM190A rearrangements provide a multitude of individualized tumor signatures and neo-antigens in cancerFrancesca Scrimieri, Eric S Calhoun, Kalpesh Patel, et al.
Oncotarget|August 12, 2010
Overexpression of POLQ confers a poor prognosis in early breast cancer patientsGeoff S Higgins, Adrian L Harris, Remko Prevo, et al.
Oncotarget|October 16, 2010
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cellsEmily J Noonan, Robert F Place, Shashwati Basak, et al.
Oncotarget|February 9, 2011
Src activates Abl to augment Robo1 expression in order to promote tumor cell migrationP Raaj Khusial, Bhaskar Vadla, Harini Krishnan, et al.
Oncotarget|April 14, 2011
Biomarkers in NHLSami N Malek
Pageof 2,673